New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

(2009) Roberto Ortiz et al.   AIDS

Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance

(2009) André Furco et al.   AIDS

Effects of Omeprazole on Plasma Levels of Raltegravir

(2009) Marian Iwamoto et al.   CLINICAL INFECTIOUS DISEASES

Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults

(2009) Sharon Walmsley et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials

(2008) Sandra de Meyer et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

(2008) M. S. Anderson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

(2008) A.-G. Marcelin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir

(2008) M. Iwamoto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

(2008) L. A. Wenning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/ zidovudine, and ethinyloestradiol/ levonorgestrel in healthy volunteers

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects

(2008) Anton L. Pozniak et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Maraviroc:in vitroassessment of drug-drug interaction potential

(2008) Ruth Hyland et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers

(2008) Monika Schöller-Gyüre et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Reviews Of Anti‐infective Agents: Maraviroc: The First of a New Class of Antiretroviral Agents

(2008) Rodger D. MacArthur et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel

(2008) Martin S. Hirsch et al.   CLINICAL INFECTIOUS DISEASES

Atazanavir Modestly Increases Plasma Levels of Raltegravir in Healthy Subjects

(2008) Marian Iwamoto et al.   CLINICAL INFECTIOUS DISEASES

Tipranavir

(2008) Jennifer S Orman et al.   DRUGS

Powder for reconstitution of the anti-HIV-1 drug TMC278 – Formulation development, stability and animal studies

(2008) Elke Van Gyseghem et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Maraviroc: integration of a new antiretroviral drug class into clinical practice

(2008) L. Vandekerckhove et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intracranial haemorrhage possibly related to Tipranavir in an HIV-1 patient with cryptococcal meningitis

(2008) G. Chrysos et al.   JOURNAL OF INFECTION

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

(2008) Jean-Michel Molina et al.   LANCET

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

(2008) Gerd Fätkenheuer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

(2008) David A. Cooper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

(2008) Roy M. Gulick et al.   NEW ENGLAND JOURNAL OF MEDICINE

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

(2008) Roy T. Steigbigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Different Meal Compositions and Fasted State on the Oral Bioavailability of Etravirine

(2008) Monika Schöller-Gyüre et al.   PHARMACOTHERAPY

Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

(2007) Marian Iwamoto et al.   JOURNAL OF CLINICAL PHARMACOLOGY